A MULTICENTER, RANDOMIZED, OPEN-LABELED, CROSS-OVER, ACTIVE-CONTROLLED, PHASE IV CLINICAL TRIAL TO EVALUATE THE PREFERENCE OF FORMULATION AND THE EFFICACY AND SAFETY OF RENAMEZIN AND KREMEZIN IN PRE-DIALYSIS PATIENTS WITH CHRONIC RENAL FAILURE: